CADE probes drugmaker for price hike

Charley Connor

28 October 2019

CADE probes drugmaker for price hike

Credit: artisteer/iStock

Brazil’s public prosecutor has complained against Gilead Sciences to the country’s competition enforcer, reportedly about the drugmaker raising the price of a hepatitis C medication by more than 1400%.